Print

AtriCure, Inc. (ATRC) Announces September Investor Conference Schedule  
8/16/2013 6:33:10 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in the development of technologies and solutions for the treatment of atrial fibrillation, or Afib, and systems for the exclusion of the left atrial appendage, today announced that it will be participating in two investor conferences in September.

Hey, check out all the research scientist jobs. Post your resume today!

//-->